Ocean Biomedical, Inc. (OCEA)
NASDAQ: OCEA · Real-Time Price · USD
0.690
0.00 (0.00%)
Nov 21, 2024, 2:05 PM EST - Market open

Ocean Biomedical Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2022 FY 2021 FY 2020 FY 2019
Period Ending
Sep '23 Dec '22 Dec '21 Dec '20 Dec '19
Selling, General & Admin
10.937.7128.411.60.2
Research & Development
0.898.4133.930.050.04
Operating Expenses
11.8116.1262.351.650.23
Operating Income
-11.81-16.12-62.35-1.65-0.23
Interest Expense
-1.31-0.17---
Interest & Investment Income
00---
Currency Exchange Gain (Loss)
0.010.010--
Other Non Operating Income (Expenses)
-70.4-1.07--0-
Pretax Income
-98.59-17.36-62.34-1.65-0.23
Net Income
-98.59-17.36-62.34-1.65-0.23
Net Income to Common
-98.59-17.36-62.34-1.65-0.23
Shares Outstanding (Basic)
1917171717
Shares Outstanding (Diluted)
1917171717
Shares Change (YoY)
-11.08%0.05%0.19%--
EPS (Basic)
-5.07-0.99-3.57-0.09-0.01
EPS (Diluted)
-5.07-0.99-3.57-0.09-0.01
Free Cash Flow
-8.6-0.99-1.05-0.06-
Free Cash Flow Per Share
-0.44-0.06-0.06-0.00-
EBIT
-11.81-16.12-62.35-1.65-0.23
Source: S&P Capital IQ. Standard template. Financial Sources.